News & Analysis on Clinical Trial Services & Contract Research And Development
To escape stagnating growth, hospital supplies firm Hospira has agreed to buy Australia's Mayne Pharma for $2bn (€1.56bn), creating the world's biggest manufacturer of generic injectable drugs.
Moving from egg-based production of vaccines to the use of cell-culture technologies in existing manufacturing plants is cheaper and quicker than building new facilities to handle a flu pandemic within the next five years, new research suggests.
Mirus Bio has made available a new RNAi tool that analyses gene function in vivo that allows scientists to study the biological and physiological impact of a change in gene expression, which is useful in the identification of new therapeutic drug targets.
Bang & Olufsen Medicom has unveiled a new disposal breath-actuated inhaler which uses a reservoir technology that reduces the daily cost of pulmonary drug delivery.
Bilcare, India's largest research-based pharmaceuticals packaging company, has bought UK-based clinical trials services (CTS) provider DHP in a bid to build itself up to be one of the few players in this sector with global servicing capability.
Drug makers need to put in place greater cold chain management capacity, in house or by outsourcing the service, as the biotech market continues to boom.
Researchers have isolated two proteins, which are involved in stopping a gene from producing a protein that is essential for cancer cell proliferation. The gene could form the basis for an anti-cancer agent that targets this mechanism.